{"id":89669,"date":"2023-11-24T13:39:37","date_gmt":"2023-11-24T08:09:37","guid":{"rendered":"http:\/\/finservwealth.com\/biocon-bets-big-on-new-class-of-weight-loss-drugs\/"},"modified":"2023-11-24T13:39:37","modified_gmt":"2023-11-24T08:09:37","slug":"biocon-bets-big-on-new-class-of-weight-loss-drugs","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/biocon-bets-big-on-new-class-of-weight-loss-drugs\/","title":{"rendered":"Biocon bets big on new class of weight-loss drugs"},"content":{"rendered":"<p> Company aims to ramp up portfolio as key drugs\u00e2\u20ac\u201dthat were actually formulated to treat diabetes\u00e2\u20ac\u201dgo off patent<\/p><div id=\"finse-1219761286\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/biocon-bets-bignew-classweight-loss-drugs_17348691.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Company aims to ramp up portfolio as key drugs\u00e2\u20ac\u201dthat were actually formulated to treat diabetes\u00e2\u20ac\u201dgo off patent Company aims to ramp up portfolio as key drugs\u00e2\u20ac\u201dthat were actually formulated to treat diabetes\u00e2\u20ac\u201dgo off patent\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/biocon-bets-bignew-classweight-loss-drugs_17348691.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Company aims to ramp up portfolio as key drugs\u00e2\u20ac\u201dthat were actually formulated to treat diabetes\u00e2\u20ac\u201dgo off patent<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/business\/biocon-bets-bignew-classweight-loss-drugs_17348691.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Company aims to ramp up portfolio as key drugs\u00e2\u20ac\u201dthat were actually formulated to treat diabetes\u00e2\u20ac\u201dgo off patent Company aims to ramp up portfolio as key drugs\u00e2\u20ac\u201dthat were actually formulated to treat diabetes\u00e2\u20ac\u201dgo off patent\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/business\/biocon-bets-bignew-classweight-loss-drugs_17348691.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Company aims to ramp up portfolio as key drugs\u00e2\u20ac\u201dthat were actually formulated to treat diabetes\u00e2\u20ac\u201dgo off patent<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-89669","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2022\/200x200\/B\/Biocon7_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/89669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=89669"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/89669\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=89669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=89669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=89669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}